PRKN and hepatocellular carcinoma: The findings indicated a dose-dependent upregulation of Pink1, Parkin, and LC3-II in Huh7 and Hepa1-6 HCC cell lines upon Sal treatment, thereby implicating Sal in the activation of mitophagy in HCC cells (Figures 2A, B).